The WHI Estrogen-Alone Trial—Do Things Look Any Better?
- 14 April 2004
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 291 (14), 1769-1771
- https://doi.org/10.1001/jama.291.14.1769
Abstract
Opinion from JAMA — The WHI Estrogen-Alone Trial—Do Things Look Any Better?Keywords
This publication has 13 references indexed in Scilit:
- National use of postmenopausal hormone therapy: annual trends and response to recent evidenceObstetrics & Gynecology, 2004
- Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women. The Women???s Health Initiative Memory Study: A Randomized, Controlled TrialObstetrical & Gynecological Survey, 2003
- FDA Orders Estrogen Safety WarningsJAMA, 2003
- Postmenopausal Hormone Therapy and Risk of StrokeCirculation, 2001
- The Protective Effects of Estrogen on the Cardiovascular SystemNew England Journal of Medicine, 1999
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- HORMONE REPLACEMENT THERAPY, HEART DISEASE, AND OTHER CONSIDERATIONSAnnual Review of Public Health, 1998
- Raloxifene is a Tissue‐Selective Agonist/Antagonist That Functions through the Estrogen ReceptorAnnals of the New York Academy of Sciences, 1995
- Hormone replacement therapy and endometrial cancer risk: A meta-analysisObstetrics & Gynecology, 1995
- Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal WomenAnnals of Internal Medicine, 1992